DORSAVI LTD - Announcements

8.82%

3.7¢

Market Cap $33.71M

Industrials Business Equipment

dorsaVi Ltd is an Australia-based company focused on developing motion analysis device... dorsaVi Ltd is an Australia-based company focused on developing motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety. Its segments include Clinical and Workplace. The Company's products include Workplace Solutions, ViMove+, ViSafe, and Research+. Workplace Solution enables employers to assess risk of injury for employees as well as test the effectiveness of proposed changes to OHS workplace design, equipment or methods based on objective evidence. Its clinical solutions (ViMove, ViMove2 and Professional Suite) provides objective assessment, monitoring outside the clinic and immediate biofeedback. The clinical market is segmented into physical therapy (physiotherapists), hospital in the home, and elite sports. Hospital in the home refers to the remote management of patients by clinicians outside of physical therapy. Elite sports refer to the management and optimization of athletes through objective evidence.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

DVL	Appendix 3B		22/06/17	366.96KB	Share
DVL	Appendix 3Y		21/06/17	146.42KB	Share
DVL	Kieser Australia signs three-year deal to use ViMove2	PRICE SENSITIVE	14/06/17	301.01KB	Share
DVL	dorsaVi Investor Update		16/05/17	5.47MB	Share
DVL	dorsaVi announces the launch of ViMove2	PRICE SENSITIVE	15/05/17	160.99KB	Share
DVL	Snowy Hydro signs with dorsaVi	PRICE SENSITIVE	11/05/17	1.09MB	Share
DVL	dorsaVi China Patent	PRICE SENSITIVE	04/05/17	126.18KB	Share
DVL	Quarterly Conference Call		27/04/17	1.11MB	Share
DVL	Appendix 4C	PRICE SENSITIVE	27/04/17	264.92KB	Share
DVL	Network Rail (High Speed) Ltd signs with dorsaVi		23/02/17	1.09MB	Share
DVL	Half Year Results Announcement		16/02/17	506.37KB	Share
DVL	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	16/02/17	569.19KB	Share
DVL	dorsaVi Investor Conference Call today at 11.00am		30/01/17	1.11MB	Share
DVL	CEO Investor Presentation		30/01/17	7.51MB	Share
DVL	Notice given under Section 708A(5)(e)		30/01/17	95.93KB	Share
DVL	Appendix 4C	PRICE SENSITIVE	30/01/17	2.15MB	Share
DVL	Appendix 3Y		27/01/17	144.21KB	Share
DVL	Appendix 3Y		27/01/17	147.45KB	Share
DVL	Appendix 3Y		27/01/17	125.57KB	Share
DVL	Appendix 3Y		27/01/17	126.29KB	Share
DVL	Appendix 3Y		27/01/17	126.35KB	Share
DVL	Notice of ceasing to be a substantial holder		25/01/17	122.06KB	Share
DVL	Notice of change of interests of substantial holder		25/01/17	1008.59KB	Share
DVL	Appendix 3B		25/01/17	345.18KB	Share
DVL	Scale Back of Share Purchase Plan		25/01/17	108.13KB	Share
DVL	Completion of Private Placement		25/01/17	90.72KB	Share
DVL	Results of General Meeting		20/01/17	110.42KB	Share
DVL	A$1 Million Share Purchase Plan closes oversubscribed		20/01/17	76.79KB	Share
DVL	dorsaVi Health Economics Paper	PRICE SENSITIVE	18/01/17	434.25KB	Share
DVL	Change in substantial holding		21/12/16	1.29MB	Share
DVL	Change in substantial holding		21/12/16	509.06KB	Share
DVL	Notice of General Meeting of Shareholders		20/12/16	637.87KB	Share
DVL	Notice given under Section 708A(5)(e)		19/12/16	94.99KB	Share
DVL	Appendix 3B		19/12/16	339.27KB	Share
DVL	Heathrow Airport undertaking 12-month project with dorsaVi	PRICE SENSITIVE	19/12/16	90.93KB	Share
DVL	Notice in accordance with ASIC Class Order CO 09/425		13/12/16	139.25KB	Share
DVL	Share Purchase Plan Offer Documentation		13/12/16	477.13KB	Share
DVL	Share Purchase Plan Offer	PRICE SENSITIVE	13/12/16	147.21KB	Share
DVL	CEO Investor Presentation		13/12/16	3.86MB	Share
DVL	$7M Private Placement and $1M Share Purchase Plan	PRICE SENSITIVE	13/12/16	100.59KB	Share
DVL	Trading Halt	PRICE SENSITIVE	09/12/16	326.01KB	Share
DVL	dorsaVi signs new US sales agent for ViSafe	PRICE SENSITIVE	06/12/16	558.81KB	Share
DVL	dorsaVi announces the launch of myViSafe	PRICE SENSITIVE	01/12/16	71.38KB	Share
DVL	dorsaVi 2016 AGM Voting Results		29/11/16	112.64KB	Share
DVL	AGM Address by Chairman and CEO Presentation		29/11/16	2.64MB	Share
DVL	dorsaVi and Mizuno working together	PRICE SENSITIVE	28/11/16	66.48KB	Share
DVL	dorsaVi wins two London Construction Awards-DVL.AX		28/10/16	78.09KB	Share
DVL	Annual Report to shareholders-DVL.AX		28/10/16	6.35MB	Share
DVL	Annual General Meeting Notice/Proxy Form-DVL.AX		28/10/16	654.88KB	Share
DVL	dorsaVi launches US based patient registry-DVL.AX	PRICE SENSITIVE	27/10/16	68.83KB	Share
DVL	CEO Investor Presentation-DVL.AX		24/10/16	14.03MB	Share
DVL	Appendix 4C - quarterly-DVL.AX	PRICE SENSITIVE	17/10/16	1.53MB	Share
DVL	Date of Annual General Meeting-DVL.AX		06/10/16	90.53KB	Share
DVL	dorsaVi awarded a Future Industries Manufacturing Grant-DVL.AX	PRICE SENSITIVE	29/09/16	87.32KB	Share
DVL	Form 605 Notice of ceasing to be a substantial holder-DVL.AX		15/09/16	195.06KB	Share
DVL	CEO Investor Presentation-DVL.AX		12/09/16	3.67MB	Share
DVL	Appendix 4E Preliminary Final Report and Annual Accounts-DVL.AX	PRICE SENSITIVE	28/08/16	1.42MB	Share
DVL	Appendix 4G and Corporate Governance Statement-DVL.AX		28/08/16	757.77KB	Share
DVL	30 June 2016 Results Announcement-DVL.AX		28/08/16	573.8KB	Share
DVL	Appendix 4G and Corporate Governance Statement-DVL.AX		25/08/16	757.77KB	Share
DVL	30 June 2016 Results Announcement-DVL.AX		25/08/16	573.8KB	Share
DVL	Appendix 4E Preliminary Final Report and Annual Accounts-DVL.AX	PRICE SENSITIVE	25/08/16	1.42MB	Share
DVL	dorsaVi announces release of ViPerform AMI in USA-DVL.AX	PRICE SENSITIVE	18/08/16	347.85KB	Share
DVL	dorsaVi ViMove being used by Wake Forest-DVL.AX	PRICE SENSITIVE	09/08/16	342.64KB	Share
DVL	dorsaVi Bioshares Conference Presentation-DVL.AX		01/08/16	5.61MB	Share
DVL	Appendix 4C - quarterly-DVL.AX	PRICE SENSITIVE	28/07/16	423.63KB	Share
DVL	dorsaVi USA market update-DVL.AX	PRICE SENSITIVE	06/07/16	359.37KB	Share
DVL	Appendix 3B-DVL.AX		14/06/16	339.63KB	Share
DVL	Revised Securities Trading Policy-DVL.AX		10/05/16	243.04KB	Share
DVL	Appendix 4C - quarterly-DVL.AX	PRICE SENSITIVE	27/04/16	766.5KB	Share
DVL	Appendix 3B-DVL.AX		05/04/16	338.44KB	Share
DVL	CMO leaves after building global sales / marketing function		21/03/16	80.93KB	Share
DVL	CEO Investor Presentation		07/03/16	3.19MB	Share
DVL	Major US physical therapy provider adopts dorsaVi products	PRICE SENSITIVE	24/02/16	100.69KB	Share
DVL	Half Year Results Announcement		08/02/16	113.64KB	Share
DVL	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	08/02/16	627.13KB	Share
DVL	dorsaVi signs Jaguar Land Rover and Toyota	PRICE SENSITIVE	03/02/16	90.33KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	242.89KB	Share
DVL	London Underground expand use of ViSafe wearable tech	PRICE SENSITIVE	28/01/16	419.79KB	Share
DVL	Ceasing to be a substantial holder		14/12/15	129.57KB	Share
DVL	Change in substantial holding		14/12/15	1.08MB	Share
DVL	Appendix 3Y		14/12/15	162.41KB	Share
DVL	Appendix 3B		14/12/15	388.54KB	Share
DVL	Appendix 3B		11/12/15	272.56KB	Share
DVL	Focus on driving dual growth across OHS and Clinical markets		11/12/15	91.07KB	Share
DVL	dorsaVi AGM Results		26/11/15	145.58KB	Share
DVL	AGM Address by Chairman and CEO Presentation		26/11/15	1.68MB	Share
DVL	Release of Securities from Escrow		23/11/15	82.02KB	Share
DVL	Allianz, Monash Health and dorsaVi team up	PRICE SENSITIVE	19/11/15	104.01KB	Share
DVL	Appendix 3B		17/11/15	270.27KB	Share
DVL	Notice of Annual General Meeting/Proxy Form		26/10/15	771.44KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/15	219.02KB	Share
DVL	Appendix 3Y		30/09/15	143.46KB	Share
DVL	Appendix 3Y		30/09/15	122.7KB	Share
DVL	Appendix 3Y		30/09/15	124.44KB	Share
DVL	Appendix 3Y		30/09/15	150.26KB	Share
DVL	Appendix 3Y		30/09/15	123.56KB	Share
DVL	Date of Annual General Meeting		30/09/15	143.43KB	Share
DVL	Appendix 4G		29/09/15	264.76KB	Share
DVL	Annual Report to shareholders		29/09/15	12.03MB	Share

DVL Appendix 3B
22/06/17		366.96KB	Share
DVL Appendix 3Y
21/06/17		146.42KB	Share
DVL Kieser Australia signs three-year deal to use ViMove2
14/06/17	PRICE SENSITIVE	301.01KB	Share
DVL dorsaVi Investor Update
16/05/17		5.47MB	Share
DVL dorsaVi announces the launch of ViMove2
15/05/17	PRICE SENSITIVE	160.99KB	Share
DVL Snowy Hydro signs with dorsaVi
11/05/17	PRICE SENSITIVE	1.09MB	Share
DVL dorsaVi China Patent
04/05/17	PRICE SENSITIVE	126.18KB	Share
DVL Quarterly Conference Call
27/04/17		1.11MB	Share
DVL Appendix 4C
27/04/17	PRICE SENSITIVE	264.92KB	Share
DVL Network Rail (High Speed) Ltd signs with dorsaVi
23/02/17		1.09MB	Share
DVL Half Year Results Announcement
16/02/17		506.37KB	Share
DVL Appendix 4D and Half Year Financial Report
16/02/17	PRICE SENSITIVE	569.19KB	Share
DVL dorsaVi Investor Conference Call today at 11.00am
30/01/17		1.11MB	Share
DVL CEO Investor Presentation
30/01/17		7.51MB	Share
DVL Notice given under Section 708A(5)(e)
30/01/17		95.93KB	Share
DVL Appendix 4C
30/01/17	PRICE SENSITIVE	2.15MB	Share
DVL Appendix 3Y
27/01/17		144.21KB	Share
DVL Appendix 3Y
27/01/17		147.45KB	Share
DVL Appendix 3Y
27/01/17		125.57KB	Share
DVL Appendix 3Y
27/01/17		126.29KB	Share
DVL Appendix 3Y
27/01/17		126.35KB	Share
DVL Notice of ceasing to be a substantial holder
25/01/17		122.06KB	Share
DVL Notice of change of interests of substantial holder
25/01/17		1008.59KB	Share
DVL Appendix 3B
25/01/17		345.18KB	Share
DVL Scale Back of Share Purchase Plan
25/01/17		108.13KB	Share
DVL Completion of Private Placement
25/01/17		90.72KB	Share
DVL Results of General Meeting
20/01/17		110.42KB	Share
DVL A$1 Million Share Purchase Plan closes oversubscribed
20/01/17		76.79KB	Share
DVL dorsaVi Health Economics Paper
18/01/17	PRICE SENSITIVE	434.25KB	Share
DVL Change in substantial holding
21/12/16		1.29MB	Share
DVL Change in substantial holding
21/12/16		509.06KB	Share
DVL Notice of General Meeting of Shareholders
20/12/16		637.87KB	Share
DVL Notice given under Section 708A(5)(e)
19/12/16		94.99KB	Share
DVL Appendix 3B
19/12/16		339.27KB	Share
DVL Heathrow Airport undertaking 12-month project with dorsaVi
19/12/16	PRICE SENSITIVE	90.93KB	Share
DVL Notice in accordance with ASIC Class Order CO 09/425
13/12/16		139.25KB	Share
DVL Share Purchase Plan Offer Documentation
13/12/16		477.13KB	Share
DVL Share Purchase Plan Offer
13/12/16	PRICE SENSITIVE	147.21KB	Share
DVL CEO Investor Presentation
13/12/16		3.86MB	Share
DVL $7M Private Placement and $1M Share Purchase Plan
13/12/16	PRICE SENSITIVE	100.59KB	Share
DVL Trading Halt
09/12/16	PRICE SENSITIVE	326.01KB	Share
DVL dorsaVi signs new US sales agent for ViSafe
06/12/16	PRICE SENSITIVE	558.81KB	Share
DVL dorsaVi announces the launch of myViSafe
01/12/16	PRICE SENSITIVE	71.38KB	Share
DVL dorsaVi 2016 AGM Voting Results
29/11/16		112.64KB	Share
DVL AGM Address by Chairman and CEO Presentation
29/11/16		2.64MB	Share
DVL dorsaVi and Mizuno working together
28/11/16	PRICE SENSITIVE	66.48KB	Share
DVL dorsaVi wins two London Construction Awards-DVL.AX
28/10/16		78.09KB	Share
DVL Annual Report to shareholders-DVL.AX
28/10/16		6.35MB	Share
DVL Annual General Meeting Notice/Proxy Form-DVL.AX
28/10/16		654.88KB	Share
DVL dorsaVi launches US based patient registry-DVL.AX
27/10/16	PRICE SENSITIVE	68.83KB	Share
DVL CEO Investor Presentation-DVL.AX
24/10/16		14.03MB	Share
DVL Appendix 4C - quarterly-DVL.AX
17/10/16	PRICE SENSITIVE	1.53MB	Share
DVL Date of Annual General Meeting-DVL.AX
06/10/16		90.53KB	Share
DVL dorsaVi awarded a Future Industries Manufacturing Grant-DVL.AX
29/09/16	PRICE SENSITIVE	87.32KB	Share
DVL Form 605 Notice of ceasing to be a substantial holder-DVL.AX
15/09/16		195.06KB	Share
DVL CEO Investor Presentation-DVL.AX
12/09/16		3.67MB	Share
DVL Appendix 4E Preliminary Final Report and Annual Accounts-DVL.AX
28/08/16	PRICE SENSITIVE	1.42MB	Share
DVL Appendix 4G and Corporate Governance Statement-DVL.AX
28/08/16		757.77KB	Share
DVL 30 June 2016 Results Announcement-DVL.AX
28/08/16		573.8KB	Share
DVL Appendix 4G and Corporate Governance Statement-DVL.AX
25/08/16		757.77KB	Share
DVL 30 June 2016 Results Announcement-DVL.AX
25/08/16		573.8KB	Share
DVL Appendix 4E Preliminary Final Report and Annual Accounts-DVL.AX
25/08/16	PRICE SENSITIVE	1.42MB	Share
DVL dorsaVi announces release of ViPerform AMI in USA-DVL.AX
18/08/16	PRICE SENSITIVE	347.85KB	Share
DVL dorsaVi ViMove being used by Wake Forest-DVL.AX
09/08/16	PRICE SENSITIVE	342.64KB	Share
DVL dorsaVi Bioshares Conference Presentation-DVL.AX
01/08/16		5.61MB	Share
DVL Appendix 4C - quarterly-DVL.AX
28/07/16	PRICE SENSITIVE	423.63KB	Share
DVL dorsaVi USA market update-DVL.AX
06/07/16	PRICE SENSITIVE	359.37KB	Share
DVL Appendix 3B-DVL.AX
14/06/16		339.63KB	Share
DVL Revised Securities Trading Policy-DVL.AX
10/05/16		243.04KB	Share
DVL Appendix 4C - quarterly-DVL.AX
27/04/16	PRICE SENSITIVE	766.5KB	Share
DVL Appendix 3B-DVL.AX
05/04/16		338.44KB	Share
DVL CMO leaves after building global sales / marketing function
21/03/16		80.93KB	Share
DVL CEO Investor Presentation
07/03/16		3.19MB	Share
DVL Major US physical therapy provider adopts dorsaVi products
24/02/16	PRICE SENSITIVE	100.69KB	Share
DVL Half Year Results Announcement
08/02/16		113.64KB	Share
DVL Appendix 4D and Half Year Financial Report
08/02/16	PRICE SENSITIVE	627.13KB	Share
DVL dorsaVi signs Jaguar Land Rover and Toyota
03/02/16	PRICE SENSITIVE	90.33KB	Share
DVL Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	242.89KB	Share
DVL London Underground expand use of ViSafe wearable tech
28/01/16	PRICE SENSITIVE	419.79KB	Share
DVL Ceasing to be a substantial holder
14/12/15		129.57KB	Share
DVL Change in substantial holding
14/12/15		1.08MB	Share
DVL Appendix 3Y
14/12/15		162.41KB	Share
DVL Appendix 3B
14/12/15		388.54KB	Share
DVL Appendix 3B
11/12/15		272.56KB	Share
DVL Focus on driving dual growth across OHS and Clinical markets
11/12/15		91.07KB	Share
DVL dorsaVi AGM Results
26/11/15		145.58KB	Share
DVL AGM Address by Chairman and CEO Presentation
26/11/15		1.68MB	Share
DVL Release of Securities from Escrow
23/11/15		82.02KB	Share
DVL Allianz, Monash Health and dorsaVi team up
19/11/15	PRICE SENSITIVE	104.01KB	Share
DVL Appendix 3B
17/11/15		270.27KB	Share
DVL Notice of Annual General Meeting/Proxy Form
26/10/15		771.44KB	Share
DVL Appendix 4C - quarterly
22/10/15	PRICE SENSITIVE	219.02KB	Share
DVL Appendix 3Y
30/09/15		143.46KB	Share
DVL Appendix 3Y
30/09/15		122.7KB	Share
DVL Appendix 3Y
30/09/15		124.44KB	Share
DVL Appendix 3Y
30/09/15		150.26KB	Share
DVL Appendix 3Y
30/09/15		123.56KB	Share
DVL Date of Annual General Meeting
30/09/15		143.43KB	Share
DVL Appendix 4G
29/09/15		264.76KB	Share
DVL Annual Report to shareholders
29/09/15		12.03MB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.7¢		Change 0.003(8.82%)		Mkt cap ! $33.71M

Open	High	Low	Value	Volume
3.4¢	3.9¢	3.4¢	$628.5K	17.13M

Buyers (Bids)

No.	Vol.	Price($)
2	1014000	3.6¢

Sellers (Offers)

Price($)	Vol.	No.
3.7¢	399996	1

View Market Depth

No.	Vol.	Price($)
1	1000000	0.036
3	1938124	0.035
3	1250000	0.034
2	161429	0.033
3	3057500	0.032

Price($)	Vol.	No.
0.038	1896578	3
0.039	2317327	4
0.040	1329556	7
0.041	260000	2
0.042	23833	1

Last trade - 16.11pm 08/08/2025 (20 minute delay)

DVL (ASX) Chart

DORSAVI LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available